CN Patent

CN113116823B — 一种脂质体及其制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2024-02-20 · 2y expired

What this patent protects

本公开涉及一种脂质体及其制备方法。具体涉及一种脂质组合物以及由它所得的脂质体，所述脂质体具有改进的释放特性。

USPTO Abstract

本公开涉及一种脂质体及其制备方法。具体涉及一种脂质组合物以及由它所得的脂质体，所述脂质体具有改进的释放特性。

Drugs covered by this patent

Bupivacaine Hydrochloride And Epinephrine (BUPIVACAINE) · Innocoll

Patent Metadata

Patent number: CN113116823B
Jurisdiction: CN
Classification: —
Expires: 2024-02-20
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hengrui Medicine Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.